Author
Listed:
- David Valentine
(Department of Biology, Brigham Young University, Provo, UT 84602, USA)
- Craig C. Teerlink
(Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA)
- James M. Farnham
(Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA)
- Kerry Rowe
(National Oncology Program, Veterans Administration, Durham, NC 27705, USA)
- Heydon Kaddas
(Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA)
- JoAnn Tschanz
(Department of Psychology, Utah State University, Logan, UT 84322, USA)
- John S. K. Kauwe
(Department of Biology, Brigham Young University, Provo, UT 84602, USA)
- Lisa A. Cannon-Albright
(Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, USA
Huntsman Cancer Institute, Salt Lake City, UT 84112, USA)
Abstract
(1) Importance: Alzheimer’s disease (AD) is complex and only partially understood. Analyzing the relationship between other more treatable or preventable diseases and AD may help in the prevention and the eventual development of treatments for AD. Risk estimation in a high-risk population, rather than a population already affected with AD, may reduce some bias in risk estimates. (2) Objective: To examine the rates of various comorbidities and cancers in individuals at high-risk for AD, but without a clinical diagnosis, relative to individuals from the same population with normal AD risk. (3) Design, Setting, and Participants: We conducted a study using data from the Utah Population Database (UPDB). The UPDB contains linked data from the Utah Cancer Registry, Utah death certificates, the Intermountain Health patient population, and the University of Utah Health patient population. Subjects were selected based on the availability of ancestral data, linked health information, and self-reported biometrics. (4) Results: In total, 75,877 participants who were estimated to be at high risk for AD based on family history, but who did not have an active AD diagnosis, were analyzed. A lower incidence of diabetes (RR = 0.95, 95% CI [0.92,0.97], p < 0.001), hypertension (RR = 0.97, 95% CI [0.95,0.99], p < 0.001), and heart disease (RR = 0.95, 95% CI [0.93,0.98], p < 0.001) was found. There was no difference in rates of cerebrovascular disease or other forms of dementia. Of the 15 types of cancer analyzed: breast (RR = 1.23, 95% CI [1.16, 1.30], p < 0.001); colorectal (RR = 1.30, 95% CI [1.21, 1.39], p < 0.001); kidney (RR = 1.49, 95% CI (1.29, 1.72), p < 0.001); lung (RR = 1.25, 95% CI [1.13, 1.37], p < 0.001); non-Hodgkin’s Lymphoma (RR = 1.29, 95% CI [1.15, 1.44], p < 0.001); pancreas (RR = 1.34, 95% CI [1.16, 1.55], p < 0.001); stomach (RR = 1.59, 95% CI [1.36, 1.86], p < 0.001); and bladder (RR = 1.40, 95% CI [1.25, 1.56], p < 0.001), cancers were observed in significant excess among individuals at high-risk for AD after correction for multiple testing. (5) Conclusions and Relevance: Since age is the greatest risk factor for the development of AD, individuals who reach more advanced ages are at increased risk of developing AD. Consistent with this, people with fewer comorbidities earlier in life are more likely to reach an age where AD becomes a larger risk. Our findings show that individuals at high risk for AD have a decreased incidence of various other diseases. This is further supported by our finding that our high-risk group was also found to have an increased incidence of various cancers, which also increase in risk with age. There is the possibility that a more meaningful or etiological relationship exists among these various comorbidities. Further research into the etiological relationship between AD and these comorbidities may elucidate these possible interactions.
Suggested Citation
David Valentine & Craig C. Teerlink & James M. Farnham & Kerry Rowe & Heydon Kaddas & JoAnn Tschanz & John S. K. Kauwe & Lisa A. Cannon-Albright, 2022.
"Comorbidity and Cancer Disease Rates among Those at High-Risk for Alzheimer’s Disease: A Population Database Analysis,"
IJERPH, MDPI, vol. 19(24), pages 1-9, December.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:24:p:16419-:d:996474
Download full text from publisher
References listed on IDEAS
- Chih-Yun Kuo & Ivo Stachiv & Tomas Nikolai, 2020.
"Association of Late Life Depression, (Non-) Modifiable Risk and Protective Factors with Dementia and Alzheimer’s Disease: Literature Review on Current Evidences, Preventive Interventions and Possible ,"
IJERPH, MDPI, vol. 17(20), pages 1-24, October.
- Heidi A Hanson & Kevin P Horn & Kelli M Rasmussen & John M Hoffman & Ken R Smith, 2017.
"Is Cancer Protective for Subsequent Alzheimer’s Disease Risk? Evidence From the Utah Population Database,"
The Journals of Gerontology: Series B, The Gerontological Society of America, vol. 72(6), pages 1032-1043.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16419-:d:996474. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.